SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: purse5/1/2019 5:22:05 PM
1 Recommendation

Recommended By
kidl

   of 49402
 
ENW the future looks great, The Aurora deal is beyond huge plus TGOD and Tilray. Aurora will dominate...…..The Globe and Mail reports in its Monday, April 29, edition that Desjardins Securities analyst John Chu began coverage on Aurora Cannabis with a "buy" rating and $16.50 share target. The Globe's David Leeder writes in the Eye On Equities column that analysts on average target the shares at $13.91. Mr. Chu says in a note: "Aurora Cannabis Inc. is uniquely positioned to dominate the domestic medical market and, in turn, the international medical market. We believe it has the size, quality standards, technology and established medical brand and patient data which it can leverage overseas, where it has the broadest reach geographically of any LP. Once the company establishes a foothold internationally on the medical side, this should position it very well when/if the international market legalizes recreational use. Aurora is no slouch on the recreational side as it has the second highest market share thus far at 13 per cent. The company's best practices philosophy, together with the addition of activist shareholder Nelson Peltz as a strategic advisor, should eventually lead to a partnership with a major [consumer packaged goods] player."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext